Dr Reddy’s introduces generic Namenda in US markets

Dr Reddy’s Laboratories has launched the United States Food & Drug Administration (FDA)  approved memantine hydrochloride tablets  USP, 5 mg and 10 mg, a therapeutic equivalent generic version of Namenda (memantine HCl) tablets in the US market on July  12, 2015.Dr-Reddy-Laboratories

The Namenda (memantine HCl) tablets brand had US sales of approximately $ 1.4 billion MAT for the most recent twelve months ending in May 2015 according to IMS Health.

Dr Reddy’s Memantine hydrochloride tablets USP, 5 mg is available in bottle count size of 60 and the memantine hydrochloride tablets USP, 10 mg are available in bottle count sizes of 60 and 500.

Don't be shellfish...Share on Facebook0Share on Google+0Share on LinkedIn0Share on StumbleUpon0Pin on Pinterest0Tweet about this on Twitter0
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

To Top